<DOC>
	<DOCNO>NCT00512577</DOCNO>
	<brief_summary>TAPS sequential trial aim investigate whether administration blood transfusion pre-operatively patient sickle cell disease ( HB SS Hb SB0 thal ) low medium risk elective surgery increase decrease overall rate peri-operative complication . The proportion patient peri-operative complication two randomise group transfuse untransfused patient compare .</brief_summary>
	<brief_title>Transfusion Alternatives Pre-Operatively Sickle Cell Disease ( TAPS )</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Sickle cell disease , either Hb SS Hb SB0 thal , confirm Hb electrophoresis , Deoxyribonucleic Acid ( DNA ) analysis High Performance Liquid Chromatography ( HPLC ) At least 24 hourse 14 day surgery date surgery give Surgery low medium risk Surgery general regional anaesthesia Written inform consent patient/parent/guardian give More six month since previous TAPS trial surgery . Having procedure involve intravascular contrast radiography image procedure On regular blood transfusion regime Had blood transfusion within last three month The planned procedure involve local anaesthetic Haemoglobin level randomisation le 6.5g/dL Children clinical history stroke ( history silent infarct would preclude randomisation ) Acute chest syndrome within last six month , patient ever require intubation mechanical ventilation treatment acute chest syndrome Oxygen saturation randomisation le 90 % Patient renal dialysis Already enter twice TAPS trial The physician unwilling randomise patient ( patient enter trial log ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>sickle cell disease</keyword>
	<keyword>pre-operative transfusion</keyword>
	<keyword>blood transfusion</keyword>
</DOC>